Daisy Xu works as a Managing Director at Vivo Capital. The firm's known portfolio counts 10 companies.
Is Daisy Xu a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Managing Director at Vivo Capital, whose known portfolio counts 10 companies
- Candid Therapeutics
- Achieve Life Science
- Immunic Therapeutics
- Kinaset Therapeutics
- OnKure Therapeutics
- ALX Oncology
- Sensei Biotherapeutics
- Diamyd Medical
- Oricell Therapeutics
- AN2 Therapeutics
Investor Profile
The listing covers sector Healthcare, and focus areas Biotech, Diagnostics, Drug Discovery and Life Science. Startups operating in these areas may find Daisy Xu relevant.
Vivo Capital appears in Late-Stage, Seed and Series B rounds across its known deals.
What the affiliated firm has backed is the closest available signal on whether Daisy Xu is worth approaching.
Colleagues at Vivo Capital
Priscilla S.
Principal
San Francisco, United States
Gaurav Aggarwal
Chief Investment Officer - Opportunity Fund
Palo Alto, United States
Jack Bech Nielsen
Managing Partner
Palo Alto, United States
Kevin Dai
Partner
San Francisco, United States
Michael Chang
Managing Partner
Singapore
Shan Fu
Managing Partner
Beijing, China
Lingfei Zhao
Principal
San Francisco, United States
Wenping Zhou
Investment Associate
Palo Alto, United States
Frequently asked questions
Who is Daisy Xu?
Daisy Xu is a private equity investor and venture capital investor based in Shanghai, China, listed as Managing Director at Vivo Capital. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to Daisy Xu personally.
What does Daisy Xu invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Diagnostics, Drug Discovery and Life Science. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Daisy Xu invest at?
Vivo Capital appears in Late-Stage, Seed and Series B rounds across its known deals, and Daisy Xu is listed there as Managing Director. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Daisy Xu listed at?
Daisy Xu is listed as Managing Director at Vivo Capital. 8 other people in the database share a firm with Daisy Xu.
How do I contact Daisy Xu?
An email address, a phone number and a LinkedIn page are on file for Daisy Xu. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal